" Trust our family to look after your family "


YMG is a ‘Research Ready’ practice!


York Medical Group Practice takes part in high-quality medical research through the Primary Care Research Network within the NHS National Institute for Health Research.  NHS medical research helps to improve the health and well-being of the nation.

Primary care is the setting for the great majority of NHS patient contact, and will play an increasing role both in the care of patients with long term conditions (such as arthritis, asthma and heart disease) and in disease prevention and early diagnosis.

We offer a wide variety of studies covering disease areas such as Arthritis,carpal tunnel syndrome, cholesterol, and Atrial Fibrillation.

We aim to give our patients the chance to take part in research if they want to. You may occasionally be offered the chance to participate in a study by letter or phone call from one of the research team. Your participation in the research studies is completely voluntary and if you decide to take part, you can withdraw from research studies at any time, without giving reason and without penalty or effect on the standard of care that you receive.

We are currently sending out patient information packs to those patients who qualify for the PANDA and the Health and Wellbeing studies.

If you receive a pack and would like to take part please fill in the form and send it in the pre-paid envelope. Thank you.

The Practice is currently involved in the following research trials:

  • Intincts
  • Early Arthritis
  • Gloria AF
  • Spire
  • Health and Wellbeing
  • Dermal
  • Panda
  • React

 If you would like to know more about research or the studies we offer you can contact the Research Nurse Nora Young at the surgery or speak to your GP.

Our current on-going Research Studies:

Early Arthritis Study 

This is a co-ordinated programme to prevent Arthritis. We are trying to identify Arthritis at a pre-clinical stage and in turn find a way to prevent Arthritis!

Read more about Arthritis.

Gloria AF Study 

Global Registry on long-term oral Anti-thrombotic treatment in patients with Atrial Fibrillation. If you have been diagnosed with an irregular heartbeat called Atrial Fibrillation within the last three months, then you are eligible to participate in the Gloria AF Study.

This study is closed for recruitment, but will be ongoing for those already participating in it for the next couple of years.

Read more about Atrial Fibrillation.

Spire Study

To investigate the efficiency and tolerability of Bococizumab for reducing the occurrence of major cardiovascular events in high risk subjects. This study is now closed for recruitment but for those participanting in it, it will be returning for the next couple of years. 

Instincts Study

To investigate whether a steroid injection is clinically effective in reducing symptoms and improving function in the short term (6 weeks) compared to a night splint in people consulting with mild to moderate carpal tunnel syndrome in primary care.

Panda Study

This study is about prescribing anitdepressants to patients.

If you are eligible for this study will receive a pack in the post. If you are interested please fill in the the questionnaire and send it in the prepaid envelope.

As part of the PANDA study you will receive anitdepressants medication or placebo. The study will last 3 months and your medication will be delivered to your surgery for you to pick up when its convenient.


This is an online peer-supported toolkit for relatives of people with psychosis or bipolar disorder. Participant will be randomly allocated by computer to receive either the REACT online intervention including access to a Resource Directory OR the Resource Directory, plus any treatment you might currently be having. You will be asked to complete some questionnaires about your experience of supporting someone with psychosis/bipolar at 3 times points, you will receive a £10 Amazon voucher as a thank you each time.

For more information or to register for this study please visit www.reacttoolkit.co.uk


This study is about Impetigo. Impetigo is a skin infection caused by bacteria and are treated normally by creams.

If you are eligible for this study you will be given an antimicrobial cream to use 3 times a day for 7 days (21 doses) and then the doctor will see you if the cream has helped. If you or your child is over the age of 18 months and would like to participate in this study please call Nora Young or Rona Good on 01904 721762. 

If you have any questions or would like to receive further information please ask your doctor or contact our Research Nurse.

You can also read more about clincal research on the NHS website.